D-0593-2024 Class III Ongoing
FDA drug recall D-0593-2024 was initiated by Zydus Pharmaceuticals (USA) Inc on Jul 2, 2024 and is designated Class III. Reason for recall: Cross contamination with other products. The recall status is ongoing. Affected quantity: 8020 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 17, 2024
- Initiation Date
- Jul 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8020 vials
Product Description
Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534, Vial NDC: 70710-1644-1, Carton NDC: 70710-1644-5.
Reason for Recall
Cross contamination with other products.
Distribution Pattern
Nationwide in the USA
Code Information
Lot L300269, Exp Date 07/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0593-2024
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026